ICON PLC
ICLR Healthcare Diagnostics & Research
ICON PLC’s revenue for fiscal 2025 (year ended December 2025) was $8.3 billion, up 0.76% from fiscal 2024.
- Revenue
- −2.86%
- EPS
- +143.2%
- Free cash flow
- −8.01%
- Total debt
- −0.86%
Quarter to September 2026, against a year earlier
Follow ICLR
Alert me
ICON PLC (ICLR) EV/FCF
As of 5 November 2026, ICON PLC (ICLR) trades at a EV/FCF of 22.6×. Over the past ten years it has ranged from 10.5× (February 2026) to 67.9× (August 2023); the current reading is higher than 48% of that period.
EV/FCF, daily
Embed this chart
Annual newest first
| Period | EV/FCF | Change |
|---|---|---|
| FY2025 | 19.8× | 9.59% |
| FY2024 | 18.0× | (30.39%) |
| FY2023 | 25.9× | (45.81%) |
| FY2022 | 47.8× | 38.14% |
| FY2021 | 34.6× | 85.57% |
| FY2020 | 18.7× | (26.06%) |
| FY2019 | 25.2× | (23.19%) |
| FY2018 | 32.9× | 70.11% |
| FY2017 | 19.3× | (8.37%) |
| FY2016 | 21.1× | (4.71%) |
Quarterly newest first
| Period | EV/FCF | Change |
|---|---|---|
| Sep 2026 | 19.8× | 10.40% |
| Jun 2026 | 17.9× | 22.25% |
| Mar 2026 | 14.6× | (26.00%) |
| Dec 2025 | 19.8× | 15.70% |
| 43 more quarters | Free account |
Against its own ten years
EV/FCF against peers
| Company | EV/FCF |
|---|---|
| GH Guardant Health, Inc. compare | −84.7× |
| ICLR ICON PLC | 22.6× |
| DGX Quest Diagnostics Incorporated compare | 23.8× |
| MEDP Medpace Holdings, Inc. compare | 25.7× |
| QGEN QIAGEN N.V. compare | 25.8× |
| LH Labcorp Holdings Inc. compare | 29.8× |
| ILMN Illumina, Inc. compare | 31.3× |
| RVTY Revvity Inc. compare | 32.6× |
| CRL Charles River Laboratories International, Inc. compare | 43.2× |
What EV/FCF is
EV/Free CF shows how the value of a whole company, debt included, compares with the free cash its business produces.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ (Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM))
More on ICLR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement